Ameriprise
QGENF

Ameriprise’s QIAGEN NV QGENF Stock Holding History

Ameriprise’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-7,954
Closed -$220K – 4030
2015
Q4 		$220K Sell
7,954
-1,965
-20% -$54.4K ﹤0.01% 3620
2015
Q3 		$256K Buy
+9,919
New +$256K ﹤0.01% 3551
2014
Q4 		– Sell
-4,682
Closed -$107K – 5504
2014
Q3 		$107K Buy
4,682
+730
+18% +$16.7K ﹤0.01% 3648
2014
Q2 		$97K Buy
3,952
+245
+7% +$6.01K ﹤0.01% 3600
2014
Q1 		$79K Buy
3,707
+410
+12% +$8.74K ﹤0.01% 3605
2013
Q4 		$78K Buy
3,297
+107
+3% +$2.53K ﹤0.01% 3490
2013
Q3 		$69K Buy
3,190
+617
+24% +$13.3K ﹤0.01% 3646
2013
Q2 		$52K Buy
+2,573
New +$52K ﹤0.01% 3701

Other funds holding QGENF

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return
HJGA
Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise's QGENF Position: Q1 2016 in Review

Ameriprise sold out of QIAGEN NV (QGENF) in Q1 2016, closing a stake of 7,954 shares — an estimated $220K sold.

Ameriprise first reported a position in QGENF in Q2 2013 and held it in 8 quarters. The position peaked at $256K in Q3 2015. 201 funds tracked by Wall St. Rank hold QGENF as of Q1 2016.

  • Ameriprise reported no remaining QIAGEN NV position as of Q1 2016 after selling out during the quarter.
  • Ameriprise sold 7,954 QIAGEN NV shares in Q1 2016, an estimated $220K.
  • Ameriprise first reported a position in QIAGEN NV in Q2 2013 and held it in 8 quarters.
  • Ameriprise's QIAGEN NV position peaked at $256K in Q3 2015.
  • 201 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2016.

Based on Ameriprise's 13F filing for Q1 2016, filed 12 May 2016.